It was previously reported that TGFβ1 upregulation after CD151 silencing could revive malignancy, suggesting that CD151 may promote renal cell carcinoma partially by regulating TGFβ1 amounts and inducing TGFβ1/Smad signaling 16. The gene discussed is TGFB1; the disease is hereditary clear cell renal cell carcinoma.